title: [Correction of urination disorders caused by benign prostatic hyperplasia in cardiac surgery].
abstract: Results of treatment in 14 patients with obstructive benign hyperplasia (adenoma) hospitalized for aortocoronary bypass surgery and coronaroplasty were analyzed. The baseline volume of residual urine ranged from 60 to 250 ml; uroflowmetry, from 4 to 8 ml/sec. During 7 day, the patient were treated with Omnic 0.4 mg a day, daily massage of prostate. Treatment substantially decrease residual urine volume and increased uroflowmetry indices. In 5 cases, the antihypertensive effect of Omnic was used for the treatment of arterial hypertension frequently accompanied by ischemic heart disease. This treatment improved urination and prevented acute ischuria before and after surgery.
authors.forename: K N
authors.initials: KN
authors.lastname: Koraev
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011470:Prostatic Hyperplasia / Q000150:complications*; D013449:Sulfonamides / Q000627:therapeutic use*; D000077409:Tamsulosin; D014555:Urination Disorders / Q000188:drug therapy* / Q000209:etiology*
chemical_list: D000317:Adrenergic alpha-Antagonists; D013449:Sulfonamides; D000077409:Tamsulosin